DRKS00034125已完成不适用
Inne MINILAB Effectiveness Study for Contraceptive Use
Feral GmbH0 个研究点目标入组 300 人开始时间: 2024年5月6日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •I1) Healthy menstruating women, with previous average menstrual cycle lengths of 22 to 35 days inclusive during the past three cycles,
- •I2) Living in Germany
- •I3) Over 18 years old
- •I4) Women using an iPhone 5S or newer, with a Wireless Fidelity (Wi-Fi) connection of at least 2.4 GhZ.
- •I5) Women agreeing to have regular heterosexual intercourse during the duration of the study (at least once per cycle).
- •I6) Women agree to not use any form of contraception during their infertile days, and must use one of the following contraceptive methods during their fertile window: abstinence, condom, or diaphragm.
- •I7) Women accept that there is a risk of unintended pregnancy associated with this study and are in this case intending to carry the pregnancy to term.
排除标准
- •E1) Women currently undergoing or having recently undergone hormonal treatment such as hormonal contraception (including oral, progesterone-only and combined hormonal methods, or any other hormonal contraceptive program), fertility treatments, or hormone replacement therapy. Since stopping the treatment, the subject has not yet had 3 regular menstrual cycles. An exception to this is hormonal emergency contraception (morning after-pill).
- •E2) Women currently using intrauterine copper devices. Since stopping the treatment, the subject has not yet had 1 regular menstrual cycle.
- •E3) Women currently undergoing or having recently undergone a treatment which may affect her menstrual cycle (this would be mentioned in the patient information leaflet of the treatment, e.g. certain antipsychotics like risperidone, or chemotherapeutic drugs like methotrexate).
- •E4) Women currently pregnant or who have recently been pregnant (until after the third consecutive period, even if the pregnancy was not carried to term).
- •E5) Women with known polycystic ovary syndrome or known endometriosis.
- •E6) Women currently breastfeeding. Women who stopped breastfeeding but did not yet have 3 regular menstrual cycles.
- •E7) This study is testing the inne MINILAB as a form of contraception. Like all contraception, there is a risk of pregnancy. Women who are not OK with any risk of pregnancy.
- •E8) Women who have had or have menopausal symptoms such as hot flashes or night sweats.
- •E9) Women with diagnosed infertility or with an infertile partner, including history of surgical sterilization.
- •E10) Participation in another clinical trial.
- •E11) Subject in custody by order of an authority or a court of law.
- •E12) Subject is a dependent person, e.g. a relative, family member, or member of the Investigator’s or Sponsor’s staff.
- •E13) Women with current wishes for pregnancy.
研究者
相似试验
招募中
2 期
Pharmacokinetic and Pharmacodynamic studyCTRI/2022/06/043170upin Research Inc
进行中（未招募）
不适用
A feasibility study into the contraceptive effect of estetrol alone or combined with either progesterone or desogestel by daily oral administration to healthy female volunteers for 28 days - Ovulation inhibition of estetrolOnly healthy volunteers will participate in this clinical trial. Intended indication: contraception.EUCTR2007-005476-14-NLPantarhei Bioscience BV
进行中（未招募）
1 期
A pilot study to examine the efficacy of vaginally administered oestradiol in the treatment of faecal incontinence in post menopausal womeFaecal IncontinenceEUCTR2005-001975-37-GBorth West London NHS Trust43
已完成
不适用
Role of diet in controlling HypertensioCTRI/2012/09/002967Mahesh Bhattacharyya Homoeopathic Medical College and Hospital30
已完成
不适用
Is task-related circuit training an effective means of providing rehabilitation to an acute stroke sample? A controlled trial.Stroke patients undergoing inpatient rehabilitationStroke -Physical Medicine / Rehabilitation - Other physical medicine / rehabilitationACTRN12605000016639Royal Adelaide Hospital78